144 related articles for article (PubMed ID: 21692746)
1. Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.
Kumar A; Vishvakarma NK; Tyagi A; Bharti AC; Singh SM
Biosci Rep; 2012 Feb; 32(1):91-104. PubMed ID: 21692746
[TBL] [Abstract][Full Text] [Related]
2. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
Kumar A; Kant S; Singh SM
Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
[TBL] [Abstract][Full Text] [Related]
3. α-Cyano-4-hydroxycinnamate induces apoptosis in Dalton's lymphoma cells: role of altered cell survival-regulatory mechanisms.
Kumar A; Kant S; Singh SM
Anticancer Drugs; 2013 Feb; 24(2):158-71. PubMed ID: 22932131
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host.
Kumar A; Vishvakarma NK; Bharti AC; Singh SM
Blood Cells Mol Dis; 2012 Feb; 48(2):137-44. PubMed ID: 22104368
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin administration on reversal of tumor-induced suppression of myelopoiesis in T-cell lymphoma bearing host.
Kumar A; Bharti AC; Singh SM
Blood Cells Mol Dis; 2012 Apr; 48(4):238-46. PubMed ID: 22421408
[TBL] [Abstract][Full Text] [Related]
6. Role of curcumin-dependent modulation of tumor microenvironment of a murine T cell lymphoma in altered regulation of tumor cell survival.
Vishvakarma NK; Kumar A; Singh SM
Toxicol Appl Pharmacol; 2011 May; 252(3):298-306. PubMed ID: 21397623
[TBL] [Abstract][Full Text] [Related]
7. A tumour stage-dependent evolution of drug resistant T cell lymphoma: role of soluble mediators of tumour and host origin.
Singh V; Singh SM
Leuk Res; 2009 May; 33(5):700-9. PubMed ID: 18930317
[TBL] [Abstract][Full Text] [Related]
8. Effect of physical exercise on tumor growth regulating factors of tumor microenvironment: implications in exercise-dependent tumor growth retardation.
Verma VK; Singh V; Singh MP; Singh SM
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):274-82. PubMed ID: 19235538
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tumor growth retardation by modulation of pH regulation in the tumor-microenvironment of a murine T cell lymphoma.
Vishvakarma NK; Singh SM
Biomed Pharmacother; 2011 Feb; 65(1):27-39. PubMed ID: 20685069
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
11. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
Gupta V; Singh SM
Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
[TBL] [Abstract][Full Text] [Related]
12. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
Singh V; Singh SM
Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
[TBL] [Abstract][Full Text] [Related]
13. Gender dimorphism of tumor growth: role of gonadal hormones in differential regulation of apoptosis of a murine T cell lymphoma.
Gupta V; Singh SM
J Biomed Sci; 2008 Mar; 15(2):147-62. PubMed ID: 17965948
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia of tumor microenvironment modulates stage-dependent tumor progression and multidrug resistance: implication of cell survival regulatory molecules and altered glucose transport.
Vishvakarma NK; Kumar A; Singh V; Singh SM
Mol Carcinog; 2013 Dec; 52(12):932-45. PubMed ID: 22566271
[TBL] [Abstract][Full Text] [Related]
15. Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines.
Singh MP; Sharma H; Singh SM
Cancer Invest; 2006 Oct; 24(6):601-10. PubMed ID: 16982465
[TBL] [Abstract][Full Text] [Related]
16. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole.
Vishvakarma NK; Singh SM
Biochimie; 2011 Oct; 93(10):1786-96. PubMed ID: 21722701
[TBL] [Abstract][Full Text] [Related]
19. Progressive tumor growth-associated altered tumor microenvironment: implications in a tumor stage-dependent modulation in survival of a murine T cell lymphoma.
Singh V; Singh SM
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1015-24. PubMed ID: 19125295
[TBL] [Abstract][Full Text] [Related]
20. Immunopotentiating effect of proton pump inhibitor pantoprazole in a lymphoma-bearing murine host: Implication in antitumor activation of tumor-associated macrophages.
Vishvakarma NK; Singh SM
Immunol Lett; 2010 Nov; 134(1):83-92. PubMed ID: 20837061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
